Within the treated ALL subgroups, significant upregulation of ADAM10 protein was observed in the VCR and MTX combination group (P=0.01,∗∗) and the DOXO-treated group (P=0.0001,∗∗∗∗), mirroring the mRNA findings. Here, ADAM10 is linked to acute lymphoblastic leukemia.